Drugs / MAXOMAT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00452725 | Oct 1997 → Jul 2010 | Noonan syndrome | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAXOMAT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00452725 ↗ |
| Modality | Protein / enzyme biologic | “biosynthetic growth hormone” NCT00452725 ↗ |